Cargando…
Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
BACKGROUND: Lack of suitable mouse models has hindered the studying of diabetic macrovascular complications. We examined the effects of type 2 diabetes on coronary artery disease and cardiac function in hypercholesterolemic low-density lipoprotein receptor-deficient apolipoprotein B100-only mice (LD...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141395/ https://www.ncbi.nlm.nih.gov/pubmed/21718508 http://dx.doi.org/10.1186/1475-2840-10-59 |
_version_ | 1782208671006064640 |
---|---|
author | Heinonen, Suvi E Merentie, Mari Hedman, Marja Mäkinen, Petri I Loponen, Elina Kholová, Ivana Bosch, Fatima Laakso, Markku Ylä-Herttuala, Seppo |
author_facet | Heinonen, Suvi E Merentie, Mari Hedman, Marja Mäkinen, Petri I Loponen, Elina Kholová, Ivana Bosch, Fatima Laakso, Markku Ylä-Herttuala, Seppo |
author_sort | Heinonen, Suvi E |
collection | PubMed |
description | BACKGROUND: Lack of suitable mouse models has hindered the studying of diabetic macrovascular complications. We examined the effects of type 2 diabetes on coronary artery disease and cardiac function in hypercholesterolemic low-density lipoprotein receptor-deficient apolipoprotein B100-only mice (LDLR(-/-)ApoB(100/100)). METHODS AND RESULTS: 18-month-old LDLR(-/-)ApoB(100/100 )(n = 12), diabetic LDLR(-/-)ApoB(100/100 )mice overexpressing insulin-like growth factor-II (IGF-II) in pancreatic beta cells (IGF-II/LDLR(-/-)ApoB(100/100), n = 14) and age-matched C57Bl/6 mice (n = 15) were studied after three months of high-fat Western diet. Compared to LDLR(-/-)ApoB(100/100 )mice, diabetic IGF-II/LDLR(-/-)ApoB(100/100 )mice demonstrated more calcified atherosclerotic lesions in aorta. However, compensatory vascular enlargement was similar in both diabetic and non-diabetic mice with equal atherosclerosis (cross-sectional lesion area ~60%) and consequently the lumen area was preserved. In coronary arteries, both hypercholesterolemic models showed significant stenosis (~80%) despite positive remodeling. Echocardiography revealed severe left ventricular systolic dysfunction and anteroapical akinesia in both LDLR(-/-)ApoB(100/100 )and IGF-II/LDLR(-/-)ApoB(100/100 )mice. Myocardial scarring was not detected, cardiac reserve after dobutamine challenge was preserved and ultrasructural changes revealed ischemic yet viable myocardium, which together with coronary artery stenosis and slightly impaired myocardial perfusion suggest myocardial hibernation resulting from chronic hypoperfusion. CONCLUSIONS: LDLR(-/-)ApoB(100/100 )mice develop significant coronary atherosclerosis, severe left ventricular dysfunction with preserved but diminished cardiac reserve and signs of chronic myocardial hibernation. However, the cardiac outcome is not worsened by type 2 diabetes, despite more advanced aortic atherosclerosis in diabetic animals. |
format | Online Article Text |
id | pubmed-3141395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31413952011-07-23 Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice Heinonen, Suvi E Merentie, Mari Hedman, Marja Mäkinen, Petri I Loponen, Elina Kholová, Ivana Bosch, Fatima Laakso, Markku Ylä-Herttuala, Seppo Cardiovasc Diabetol Original Investigation BACKGROUND: Lack of suitable mouse models has hindered the studying of diabetic macrovascular complications. We examined the effects of type 2 diabetes on coronary artery disease and cardiac function in hypercholesterolemic low-density lipoprotein receptor-deficient apolipoprotein B100-only mice (LDLR(-/-)ApoB(100/100)). METHODS AND RESULTS: 18-month-old LDLR(-/-)ApoB(100/100 )(n = 12), diabetic LDLR(-/-)ApoB(100/100 )mice overexpressing insulin-like growth factor-II (IGF-II) in pancreatic beta cells (IGF-II/LDLR(-/-)ApoB(100/100), n = 14) and age-matched C57Bl/6 mice (n = 15) were studied after three months of high-fat Western diet. Compared to LDLR(-/-)ApoB(100/100 )mice, diabetic IGF-II/LDLR(-/-)ApoB(100/100 )mice demonstrated more calcified atherosclerotic lesions in aorta. However, compensatory vascular enlargement was similar in both diabetic and non-diabetic mice with equal atherosclerosis (cross-sectional lesion area ~60%) and consequently the lumen area was preserved. In coronary arteries, both hypercholesterolemic models showed significant stenosis (~80%) despite positive remodeling. Echocardiography revealed severe left ventricular systolic dysfunction and anteroapical akinesia in both LDLR(-/-)ApoB(100/100 )and IGF-II/LDLR(-/-)ApoB(100/100 )mice. Myocardial scarring was not detected, cardiac reserve after dobutamine challenge was preserved and ultrasructural changes revealed ischemic yet viable myocardium, which together with coronary artery stenosis and slightly impaired myocardial perfusion suggest myocardial hibernation resulting from chronic hypoperfusion. CONCLUSIONS: LDLR(-/-)ApoB(100/100 )mice develop significant coronary atherosclerosis, severe left ventricular dysfunction with preserved but diminished cardiac reserve and signs of chronic myocardial hibernation. However, the cardiac outcome is not worsened by type 2 diabetes, despite more advanced aortic atherosclerosis in diabetic animals. BioMed Central 2011-06-30 /pmc/articles/PMC3141395/ /pubmed/21718508 http://dx.doi.org/10.1186/1475-2840-10-59 Text en Copyright ©2011 Heinonen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Investigation Heinonen, Suvi E Merentie, Mari Hedman, Marja Mäkinen, Petri I Loponen, Elina Kholová, Ivana Bosch, Fatima Laakso, Markku Ylä-Herttuala, Seppo Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice |
title | Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice |
title_full | Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice |
title_fullStr | Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice |
title_full_unstemmed | Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice |
title_short | Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice |
title_sort | left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic ldl-receptor deficient apolipoprotein b100-only mice |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141395/ https://www.ncbi.nlm.nih.gov/pubmed/21718508 http://dx.doi.org/10.1186/1475-2840-10-59 |
work_keys_str_mv | AT heinonensuvie leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT merentiemari leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT hedmanmarja leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT makinenpetrii leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT loponenelina leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT kholovaivana leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT boschfatima leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT laaksomarkku leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice AT ylaherttualaseppo leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice |